GeneSort vs Mammoth Biosciences
GeneSort vs Mammoth Biosciences, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: GeneSort is on 39/100 and Mammoth Biosciences on 63/100.
Where each one leads
GeneSort
Leads on none of the measures we hold for both companies.
Mammoth Biosciences
- our overall score: 63/100 against 39/100
- agent readiness: 35/100 against 21/100
- domain rating: 53/100 against 3/100
- headcount: 165 against 4
- headcount growth: +5.8% against -4.9%
- funding raised: $460M against $2.2M
- LinkedIn following: 57,986 against 622
At a glance
| Measure | GeneSort | Mammoth Biosciences |
|---|---|---|
| What it is | A molecular diagnostics company focused on integrating genomics with personalized therapeutic approaches for cancer. | Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics. |
| Category | Healthcare, Next Generation Sequencing, Cancer, Genomics | Biotechnology, Drug Discovery, Genomics, CRISPR Technology |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Platform |
| Founded | 2014 | 2017 |
| Headquarters | Tel Aviv, Israel | Brisbane, United States |
| Status | Inactive | Active |
Size, funding and growth
| Measure | GeneSort | Mammoth Biosciences |
|---|---|---|
| Employees | 4 | 165 |
| Headcount growthLast 12 months | -4.9% | +5.8% |
| Total funding | $2.2M | $460M |
| Latest round | Not published | Funding Round |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 622 | 57,986 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | GeneSort | Mammoth Biosciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 39/100 | 63/100 |
| Traction | 39/100 | 60/100 |
| Team | Not published | 70/100 |
| Search visibility | 24/100 | 35/100 |
| Quality | 48/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (35/100) |
| Domain ratingLink authority, 0-100 | 3/100 | 53/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | GeneSort | Mammoth Biosciences |
|---|---|---|
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4 |
GeneSort vs Mammoth Biosciences: common questions
Which is better, GeneSort or Mammoth Biosciences?
On our 0-100 score Mammoth Biosciences rates higher (63/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do GeneSort and Mammoth Biosciences compare on the numbers?
Mammoth Biosciences leads on our overall score (63/100 against 39/100), agent readiness (35/100 against 21/100), domain rating (53/100 against 3/100), headcount (165 against 4), headcount growth (+5.8% against -4.9%), funding raised ($460M against $2.2M), LinkedIn following (57,986 against 622).
Read the full GeneSort review and pricing or the Mammoth Biosciences review and pricing. You can also browse other GeneSort alternatives we track.